Navigating the procurement of specialized bioenergetic compounds for metabolic and neurobiological research requires strict adherence to analytical purity standards. PX1 Research supplies high-purity NAD+ research formulations engineered strictly for in vitro assays, cell culture studies, and preclinical rodent models. Every batch is manufactured in the United States, tested in ISO 17025 accredited laboratories, and accompanied by comprehensive, lot-specific analytical documentation.
Navigating the procurement of specialized bioenergetic compounds for metabolic and neurobiological research requires strict adherence to analytical purity standards. PX1 Research supplies high-purity NAD+ research formulations engineered strictly for in vitro assays, cell culture studies, and preclinical rodent models. Every batch is manufactured in the United States, tested in ISO 17025 accredited laboratories, and accompanied by comprehensive, lot-specific analytical documentation.
Principal investigators and laboratory managers looking to buy NAD+ nasal spray online for experimental protocols must verify that compounds meet rigorous reference-standard metrics. Research-grade Nicotinamide Adenine Dinucleotide (NAD+) intended for mucosal delivery models or central nervous system administration studies requires high chemical stability, defined concentrations, and strict absence of microbiological contamination.
PX1 Research delivers standardized NAD+ research formulations backed by complete transparency. Designed exclusively for preclinical laboratory investigation, our solutions undergo exhaustive purity verification to ensure consistent, reproducible data across metabolic, genomic stability, and neurodegeneration assays.
Nicotinamide Adenine Dinucleotide (NAD+) is a ubiquitous essential coenzyme found in all living cells, existing in both oxidized (NAD+) and reduced (NADH) states. It plays a foundational role as a electron carrier in mitochondrial oxidative phosphorylation, glycolysis, and the citric acid cycle. Beyond its core role in energy metabolism, NAD+ functions as an essential substrate for signaling enzymes, including sirtuins (SIRT1–SIRT7), poly(ADP-ribose) polymerases (PARPs), and cyclic ADP-ribose synthases (CD38/CD157).
When evaluated as an intranasal solution in animal models, NAD+ allows investigators to bypass systemic hepatic clearance and study direct central nervous system kinetics. Solubilized in buffered, iso-osmotic laboratory vehicles, research-grade intranasal formulations enable precise volumetric micro-dosing in controlled preclinical experimental setups.
Preclinical literature demonstrates that intracellular NAD+ pools decline systematically during cellular senescence and metabolic stress models. In rodent studies, restoring nuclear and mitochondrial NAD+ concentrations activates SIRT1 and SIRT3, promoting mitochondrial biogenesis, optimizing oxidative phosphorylation, and upregulating antioxidant enzyme pathways.
In vitro assays indicate that NAD+ availability regulates PARP-1 enzymatic activity during DNA single-strand repair processes. However, hyperactivation of PARP-1 due to severe oxidative stress rapidly depletes cytosolic NAD+ reserves, leading to bioenergetic collapse. Laboratory models investigating NAD+ mechanisms utilize intranasal or direct cellular applications to explore whether exogenous replenishment attenuates metabolic arrest and preserves mitochondrial membrane potential under ischemic or neurotoxic challenges.
Intranasal administration routes in rodent models provide a recognized mechanism for investigating direct transport pathways along olfactory and trigeminal nerve bundles into the olfactory bulb and brain parenchyma. Animal models indicate that direct mucosal application avoids initial gastrointestinal breakdown and hepatic first-pass metabolism, yielding altered pharmacokinetic profiles compared to systemic intraperitoneal or oral dosing.
In experimental models of neuroinflammation and ischemic stroke, intranasal NAD+ solutions have been observed to cross the blood-brain barrier via passive extracellular diffusion and active transport mechanisms. Researchers investigating central bioenergetics examine how rapid elevations in cortical and hippocampal NAD+ pools modulate microglial activation markers, mitigate neuro-inflammatory cytokines, and maintain cellular ATP production.
When structuring bioenergetic research projects, laboratories frequently evaluate direct NAD+ against intermediate precursors and mitochondrial-targeted compounds. While direct NAD+ delivers the active coenzyme directly to cellular systems, intermediate compounds such as NMN precursor research reagents depend on rate-limiting enzymatic conversions via nicotinamide mononucleotide adenylyltransferases (NMNATs). Comparative rodent studies analyze whether direct NAD+ administration offers distinct kinetic advantages over precursor molecules in acute metabolic challenge models.
Beyond coenzymes and nucleotide derivatives, researchers investigating cellular bioenergetics often combine or contrast NAD+ with mitochondria-targeted peptides. For example, SS-31 peptide formulations target cardiolipin within the inner mitochondrial membrane to reduce ROS emission, while MOTS-c peptide reagents regulate nuclear gene expression during metabolic stress. Integrating these diverse tools allows investigators to construct multi-target experimental frameworks for cellular respiration, aging, and metabolic regulation. View our full catalog of all research peptides for comprehensive study design.
Direct NAD+ solutions demonstrate sensitivity to temperature variations, prolonged light exposure, and pH fluctuations. To preserve chemical integrity and prevent spontaneous hydrolysis into nicotinamide and ADP-ribose, liquid or lyophilized NAD+ compounds must be stored at temperature-controlled conditions (-20°C or colder for long-term storage) away from direct light.
When preparing working stock solutions for in vitro assays, researchers should utilize sterile, double-distilled, endotoxin-free water or buffered saline (such as PBS, pH 7.2–7.4). Aliquoting stock solutions into single-use microcentrifuge tubes minimizes freeze-thaw degradation cycles. Unused liquid intranasal preparations maintained at 2°C to 8°C should be utilized within established experimental timelines to ensure consistent concentration accuracy throughout testing.
Acquiring valid research outcomes requires purchasing compounds from suppliers that enforce rigorous analytical quality controls. Unverified reagents risk introducing unknown degradation products, residual organic solvents, or heavy metals into cell culture systems, skewing bioenergetic measurements and cell viability assays.
At PX1 Research, every production lot undergoes independent verification by third-party ISO 17025 accredited laboratories. We utilize Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to establish purity levels consistently exceeding 98% or 99%, and Electrospray Ionization Mass Spectrometry (ESI-MS) to verify exact molecular weight and chemical identity. Detailed laboratory testing procedures and analytical protocols are archived within our PX1 research database.
Bacterial endotoxins (lipopolysaccharides) introduce severe confounding variables into immunological, neuronal, and cellular assays. Even low levels of endotoxin contamination can trigger non-specific toll-like receptor 4 (TLR4) activation, masking true experimental responses or inducing premature cell death.
PX1 Research conducts quantitative Chromogenic Recombinant Factor C (rFC) or LAL endotoxin testing on all laboratory batches to confirm endotoxin levels strictly below <0.05 EU/mg. Every order includes access to lot-traceable Certificates of Analysis (COAs), clearly presenting HPLC chromatograms, mass spectra, and endotoxin assay values so researchers can satisfy institutional compliance standards.
PX1 Research streamlines reagent procurement for academic institutions, biotechnology organizations, and government research facilities. Operating out of advanced, GMP-compliant facilities in California and Arizona, we maintain immediate inventory availability to avoid study disruptions.
Orders placed Monday through Friday before 12:00 PM PST feature same-day dispatch. Institutional buyers interested in high-volume baseline testing or standing monthly orders can access tailored account structures via our dedicated wholesale laboratory program.
What is the purity level of PX1 Research NAD+ nasal spray?
PX1 Research NAD+ nasal solutions are verified at ≥98% purity by independent ISO 17025 accredited third-party laboratories using RP-HPLC and mass spectrometry analysis.
How should NAD+ nasal spray be stored in a laboratory setting?
Unopened stock should be stored refrigerated at 2°C to 8°C for short-term experimental protocols or frozen at -20°C for long-term preservation, protected from direct light and moisture.
Is this product intended for human use or clinical treatment?
No. All compounds supplied by PX1 Research are manufactured strictly for laboratory research, in vitro assays, and preclinical animal investigation. They are not for human or animal consumption, medical treatment, or clinical use.
How can researchers access the Certificate of Analysis (COA) for a specific lot?
Lot-specific COAs are downloadable directly from the PX1 Research website by matching the lot number printed on the product vial, providing complete transparency into HPLC chromatograms and mass spectra.
What endotoxin testing standards are applied to PX1 Research compounds?
Every batch undergoes LAL or rFC endotoxin testing, ensuring levels remain strictly below <0.05 EU/mg to prevent non-specific immune activation during cell culture or animal research.
What is the primary mechanism of NAD+ evaluated in preclinical models?
In preclinical literature, NAD+ acts as an essential coenzyme for mitochondrial electron transport and a substrate for SIRT1–SIRT7 and PARP enzymes involved in bioenergetics, epigenetic signaling, and DNA repair.
Where does PX1 Research manufacture and ship its research compounds?
PX1 Research manufactures all compounds in GMP-compliant facilities within the United States, shipping directly from distribution hubs located in California and Arizona.
What vehicles or buffers are used in research-grade intranasal formulations?
Research formulations are solubilized in sterile, iso-osmotic, pH-buffered laboratory saline designed to maintain molecular stability and precise volumetric measurement during preclinical dosing.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.